Newsletter Subject

Surgeons In France Successfully Transplant Nose Grown On Woman's Arm To Her Face – The Medical Futurist Newsletter

From

medicalfuturist.com

Email Address

newsletter@medicalfuturist.com

Sent On

Tue, Nov 29, 2022 02:03 PM

Email Preheader Text

The surgical team successfully re-vascularised the patient’s nasal cavity, connecting the blood

The surgical team successfully re-vascularised the patient’s nasal cavity, connecting the blood vessels by microsurgery What a [major breakthrough]( from a French surgical team to successfully transplant a nose grown on the patient's forearm. It's so great to see 3D bioprinting being implemented into more traditional surgical reconstruction methods. On a non-medical note: as the last instalment of our book review series, here is the final episode, about [my absolute favourites from 2022](. Two non-fiction and two fiction, maybe it's some inspiration before the holiday season. I hope you will find the newsletter useful! Best regards, Berci Bertalan Meskó, PhD The Medical Futurist [3D-PRINTED NOSE GREW ON WOMAN'S ARM AFTER SHE LOST HERS TO CANCER]( "The operation involved ear, nose and throat experts as well as plastic surgery teams at the Toulouse University Hospital and the Claudius Regaud Institute and took place at the Toulouse-Oncopole University Cancer Institute. They said that they managed to successfully re-vascularise the patient’s nasal cavity, connecting the blood vessels by performing microsurgery." [READ MORE]( WHY DO I THINK IT'S IMPORTANT? 3D bioprinting is a fascinating area with amazing potential. Every case where it meets actual surgical needs and processes paves the way for it to help even more patients. [GENE PATHWAY ANALYSIS IN ACTION - 3X4 DNA TEST REVIEW]( --------------------------------------------------------------- In the past couple of years, I have taken at least 10 genetic tests, including this latest DNA test from 3×4 Genetics. This may seem excessive, but I have my reasons. I graduated as a genetic specialist and completed my PhD as a clinical genomics researcher. My original field never ceases to fascinate me. I’m curious about how these tests advance and hope to provide insights for patients worldwide about what they can expect to learn from such tests. [READ MORE]( WHY DO I THINK IT'S IMPORTANT? Pathway analysis coupled with good counselling offers real practical knowledge. This might be the best test I've ever tried in terms of usefulness. The downside: it's only available in the US and South Africa. [GET UP TO SPEED: A GUIDE TO ARTIFICIAL INTELLIGENCE IN HEALTHCARE]( --------------------------------------------------------------- Artificial intelligence will be one of the major forces fundamentally transforming healthcare in the 21st century. In the latest update of our AI book, we summarized everything there is to know about its potential, the use cases and about what we can and can't expect from algorithms. [GET IT HERE]( [FDA APPROVES FIRST GENE THERAPY FOR HEMOPHILIA B]( --------------------------------------------------------------- Just 3 months after the US Food and Drug Administration approved the first cell-based gene therapy for treating Beta-thalassemia, a disorder requiring regular blood transfusions, now they have approved the first gene therapy for hemophilia B! "The therapy, called Hemgenix and developed by the Dutch biotechnology company UniQure, is for the less common “B” form of hemophilia, which is estimated to represent about 15% of all patients with the disease." [READ MORE]( WHY IT'S IMPORTANT? A downside is that the one-time treatment’s price is $3.5 million as of now. We still need to see reliable calculations on cost savings for the overall healthcare system before it gets available on a wider scale. [RECOMMENDED READS: MY 2+2 FAVORITE BOOKS IN 2022]( --------------------------------------------------------------- If you follow The Medical Futurist's social media channels, you're undoubtedly aware that I'm an avid reader who spends hours browsing through reviews to select the next book to read. This time, I'd like to present my favorite books from this year! I have chosen two works of science fiction and two works of nonfiction. [WATCH VIDEO]( [PATIENTS PREFER TELEHEALTH FOR COMMON ILLNESSES, STUDY SHOWS]( --------------------------------------------------------------- Of course, patients prefer telehealth for common illnesses! Why would they want to stand in line with other sick people when they only need medical advice they could get in a 3-minute telehealth visit? However, it doesn't mean that providing telehealth visits is easy. It's a new situation for patients and physicians alike, and they both have to learn how to build relationships through such technology. [READ MORE]( WHY DO I THINK IT'S IMPORTANT? Telehealth is becoming the new norm to tackle doctor shortages worldwide, which is one of the [dire problems of all systems](. [THERANOS' HOLMES SENTENCED TO MORE THAN 11 YEARS IN PRISON]( --------------------------------------------------------------- Elizabeth Holmes, the founder of the blood-testing startup Theranos, was found guilty and sentenced to more than 11 years in prison for defrauding investors. "Holmes, 38, was convicted of conspiracy to defraud investors and three counts of wire fraud in January. She faced up to 20 years in prison, and her defence team argued she should be given a maximum sentence of 18 months. Prosecutors aimed to sentence her to 15 years in prison." [READ MORE]( WHY DO I THINK IT'S IMPORTANT? One of the biggest scandals, and indeed the biggest scam of the digital health era, is over. MORE NEWS ABOUT THE FUTURE OF MEDICINE --------------------------------------------------------------- GLOBAL VISION – [What Role Should The WHO Play In Regulating Digital Health Access And Information?]( NO BEEPS – [The metaverse isn’t even here yet—but ambient computing is already very real]( TACKLE COPD – [Activity tracker data can shed light on heart health]( HELLO?! – [Smartphone as an electronic stethoscope: factors influencing heart sound quality]( [color-forwardtofriend-48.png](mailto:berci@medicalfuturist.com) [color-facebook-48.png]( [color-youtube-48.png]( [color-linkedin-48.png]( [color-twitter-48.png]( [color-instagram-48.png]( © The Medical Futurist 2022 This email was sent to {EMAIL} [why did I get this?]( [unsubscribe from this list]( [update subscription preferences]( Medical Futurist · Budapest · Budapest, Pest 1118 · Hungary

Marketing emails from medicalfuturist.com

View More
Sent On

05/11/2024

Sent On

22/10/2024

Sent On

01/10/2024

Sent On

24/09/2024

Sent On

17/09/2024

Sent On

16/09/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.